This article is more than 5 years old. Information may no longer be current.

NovaBay reports $1.7 million loss in second quarter

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

NovaBay Pharmaceuticals reported a net loss of $1.7 million, or $0.11 per share, in the second quarter of 2017 compared with a net loss of $2.7 million, or $0.36 per share, in 2016’s second quarter.

Net sales were up 55% from $2.7 million a year ago to $4.1 million in the second quarter, according to a press release.

Operating loss was $1.8 million compared with $2.2 million in 2016’s second quarter.

General and administrative expenses increased from $1.3 million to $1.7 million, while research and development costs decreased to $70,000 from $0.3 million.